跳至主要内容
临床试验/DRKS00026806
DRKS00026806已完成4 期

Clinical Performance of the Nipro ELISIO HX Medium Cut-Off Dialyzer - Performance of the Nipro ELISIO HX Dialyzer

eXcorLab GmbH0 个研究点目标入组 6 人开始时间: 2021年10月8日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
eXcorLab GmbH
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Age = 18 years
  • End-stage kidney disease
  • Chronic hemodialysis treatment for more than three months
  • Hematocrit = 30 %
  • Stable anticoagulation and erythropoietin regimen
  • No vascular access-related problems (A/V-fistula or bi-flow catheter)
  • No ongoing infection
  • Signed informed consent form

排除标准

  • Inclusion criteria not met
  • Known HIV infection.
  • Pregnancy
  • Unstable clinical condition (e.g., cardiac or vascular instability)
  • Life expectancy less than 12 months
  • Known coagulation problems
  • Participation in another study interfering with the planned trial

研究者

发起方
eXcorLab GmbH

相似试验